Protective effect and mechanism of different proportions of " Danggui-Kushen" herb pair on ischemic heart disease

Xu Yuan; Kemeng Liu; Peiliang Dong; Hua Han

doi:10.1016/j.heliyon.2023.e22150

Protective effect and mechanism of different proportions of " Danggui-Kushen" herb pair on ischemic heart disease

Heliyon. 2023 Nov 10;9(11):e22150. doi: 10.1016/j.heliyon.2023.e22150. eCollection 2023 Nov.

Authors

Xu Yuan¹, Kemeng Liu², Peiliang Dong², Hua Han¹

Affiliations

¹ College of Medicine, Heilongjiang University of Chinese Medicine, 24 Heping Road, Harbin, China.
² Institute of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.

Abstract

This study aims to investigate the protective effect and mechanism of "Danggui-Kushen" herb pair (DKHP) on ischemic heart disease (IHD). The rat model of myocardial reperfusion injury (MIRI) was established by ligation of the left anterior descending coronary artery. Rats were randomly divided into seven groups and administered orally for 7 days: control group, IHD group, DKHP1:1 group, DKHP1:2 group, DKHP2:1 group, DKHP1:3 group, DKHP3:1 group, the dosage was 2.7 g/kg. Measure electrocardiogram (ECG), myocardial infarction and injury assessment, Hematoxylin and eosin (HE) staining to evaluate myocardial injury and the protective effect of DKHP. Lactate dehydrogenase (LDH), Reactive oxygen species (ROS), IL-1β and IL-6 kit detection, immunohistochemical analysis, establishment of H9c2 cardiomyocyte hypoxia (Hypoxia) model, DKHP pretreatment for 3 h, MTT method to detect cell survival rate, cell immunofluorescence to observe NF- The expression of TLR-4, NF-κB, p-NF-κB, IKβα, p-IKβα, HIF-1α, VEGF and other genes and proteins were detected by κB nuclear translocation, mitochondrial membrane potential measurement, Western blot and Polymerase Chain Reaction (PCR). Compared with the model group, DKHP can reduce the size of myocardial infarction, reduce the levels of factors such as LDH, ROS, IL-1β and IL-6, and improve the cell survival rate; Compared with the model group, DKHP can inhibit the nuclear transfer of NF-κB and reduce mitochondrial damage; the results of immunohistochemical analysis, PCR and Western blot showed that compared with the model group, DKHP can reduce TLR-4, p-NF-κB, Expression levels of p-IKβα, HIF-1α, VEGF and other proteins. Reveal that DKHP may play a protective role in ischemic heart disease by reducing inflammation and oxidative stress damage. DKHP may have protective effect on ischemic heart disease, and its mechanism may be through reducing inflammatory response and oxidative stress damage to achieve this protective effect.

Keywords: HIF-1α; Ischemic heart disease; Myocardium; NF-κB; “Danggui-Kushen” herb pair.